Alimta - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

The global market for Alimta was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Alimta was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Alimta was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Alimta was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Alimta include Eli Lilly, Abbott Healthcare, Cadila Healthcare and Eagle Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Alimta, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Alimta by region & country, by Type, and by Application.

The Alimta market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alimta.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Alimta manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Alimta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Alimta in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Alimta Product Introduction
    1.2 Global Alimta Market Size Forecast
        1.2.1 Global Alimta Sales Value (2019-2030)
        1.2.2 Global Alimta Sales Volume (2019-2030)
        1.2.3 Global Alimta Sales Price (2019-2030)
    1.3 Alimta Market Trends & Drivers
        1.3.1 Alimta Industry Trends
        1.3.2 Alimta Market Drivers & Opportunity
        1.3.3 Alimta Market Challenges
        1.3.4 Alimta Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Alimta Players Revenue Ranking (2023)
    2.2 Global Alimta Revenue by Company (2019-2024)
    2.3 Global Alimta Players Sales Volume Ranking (2023)
    2.4 Global Alimta Sales Volume by Company Players (2019-2024)
    2.5 Global Alimta Average Price by Company (2019-2024)
    2.6 Key Manufacturers Alimta Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Alimta Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Alimta
    2.9 Alimta Market Competitive Analysis
        2.9.1 Alimta Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Alimta Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alimta as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 100mg
        3.1.2 500mg
    3.2 Global Alimta Sales Value by Type
        3.2.1 Global Alimta Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Alimta Sales Value, by Type (2019-2030)
        3.2.3 Global Alimta Sales Value, by Type (%) (2019-2030)
    3.3 Global Alimta Sales Volume by Type
        3.3.1 Global Alimta Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Alimta Sales Volume, by Type (2019-2030)
        3.3.3 Global Alimta Sales Volume, by Type (%) (2019-2030)
    3.4 Global Alimta Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Pleural Mesothelioma
        4.1.2 Non-small Cell Lung Cancer
    4.2 Global Alimta Sales Value by Application
        4.2.1 Global Alimta Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Alimta Sales Value, by Application (2019-2030)
        4.2.3 Global Alimta Sales Value, by Application (%) (2019-2030)
    4.3 Global Alimta Sales Volume by Application
        4.3.1 Global Alimta Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Alimta Sales Volume, by Application (2019-2030)
        4.3.3 Global Alimta Sales Volume, by Application (%) (2019-2030)
    4.4 Global Alimta Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Alimta Sales Value by Region
        5.1.1 Global Alimta Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Alimta Sales Value by Region (2019-2024)
        5.1.3 Global Alimta Sales Value by Region (2025-2030)
        5.1.4 Global Alimta Sales Value by Region (%), (2019-2030)
    5.2 Global Alimta Sales Volume by Region
        5.2.1 Global Alimta Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Alimta Sales Volume by Region (2019-2024)
        5.2.3 Global Alimta Sales Volume by Region (2025-2030)
        5.2.4 Global Alimta Sales Volume by Region (%), (2019-2030)
    5.3 Global Alimta Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Alimta Sales Value, 2019-2030
        5.4.2 North America Alimta Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Alimta Sales Value, 2019-2030
        5.5.2 Europe Alimta Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Alimta Sales Value, 2019-2030
        5.6.2 Asia Pacific Alimta Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Alimta Sales Value, 2019-2030
        5.7.2 South America Alimta Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Alimta Sales Value, 2019-2030
        5.8.2 Middle East & Africa Alimta Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Alimta Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Alimta Sales Value
        6.2.1 Key Countries/Regions Alimta Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Alimta Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Alimta Sales Value, 2019-2030
        6.3.2 United States Alimta Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Alimta Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Alimta Sales Value, 2019-2030
        6.4.2 Europe Alimta Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Alimta Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Alimta Sales Value, 2019-2030
        6.5.2 China Alimta Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Alimta Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Alimta Sales Value, 2019-2030
        6.6.2 Japan Alimta Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Alimta Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Alimta Sales Value, 2019-2030
        6.7.2 South Korea Alimta Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Alimta Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Alimta Sales Value, 2019-2030
        6.8.2 Southeast Asia Alimta Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Alimta Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Alimta Sales Value, 2019-2030
        6.9.2 India Alimta Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Alimta Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Eli Lilly
        7.1.1 Eli Lilly Company Information
        7.1.2 Eli Lilly Introduction and Business Overview
        7.1.3 Eli Lilly Alimta Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Eli Lilly Alimta Product Offerings
        7.1.5 Eli Lilly Recent Development
    7.2 Abbott Healthcare
        7.2.1 Abbott Healthcare Company Information
        7.2.2 Abbott Healthcare Introduction and Business Overview
        7.2.3 Abbott Healthcare Alimta Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Abbott Healthcare Alimta Product Offerings
        7.2.5 Abbott Healthcare Recent Development
    7.3 Cadila Healthcare
        7.3.1 Cadila Healthcare Company Information
        7.3.2 Cadila Healthcare Introduction and Business Overview
        7.3.3 Cadila Healthcare Alimta Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Cadila Healthcare Alimta Product Offerings
        7.3.5 Cadila Healthcare Recent Development
    7.4 Eagle Pharmaceuticals
        7.4.1 Eagle Pharmaceuticals Company Information
        7.4.2 Eagle Pharmaceuticals Introduction and Business Overview
        7.4.3 Eagle Pharmaceuticals Alimta Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Eagle Pharmaceuticals Alimta Product Offerings
        7.4.5 Eagle Pharmaceuticals Recent Development

 8 Industry Chain Analysis
    8.1 Alimta Industrial Chain
    8.2 Alimta Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Alimta Sales Model
        8.5.2 Sales Channel
        8.5.3 Alimta Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Alimta Market Trends
    Table 2. Alimta Market Drivers & Opportunity
    Table 3. Alimta Market Challenges
    Table 4. Alimta Market Restraints
    Table 5. Global Alimta Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Alimta Revenue Market Share by Company (2019-2024)
    Table 7. Global Alimta Sales Volume by Company (2019-2024) & (Kg)
    Table 8. Global Alimta Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Alimta Price by Company (2019-2024) & (USD/g)
    Table 10. Key Manufacturers Alimta Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Alimta Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Alimta
    Table 13. Global Alimta Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alimta as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Alimta Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Alimta Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Alimta Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Alimta Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Alimta Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Alimta Sales Volume by Type: 2019 VS 2023 VS 2030 (Kg)
    Table 22. Global Alimta Sales Volume by Type (2019-2024) & (Kg)
    Table 23. Global Alimta Sales Volume by Type (2025-2030) & (Kg)
    Table 24. Global Alimta Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Alimta Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Alimta Price by Type (2019-2024) & (USD/g)
    Table 27. Global Alimta Price by Type (2025-2030) & (USD/g)
    Table 28. Global Alimta Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Alimta Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Alimta Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Alimta Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Alimta Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Alimta Sales Volume by Application: 2019 VS 2023 VS 2030 (Kg)
    Table 34. Global Alimta Sales Volume by Application (2019-2024) & (Kg)
    Table 35. Global Alimta Sales Volume by Application (2025-2030) & (Kg)
    Table 36. Global Alimta Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Alimta Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Alimta Price by Application (2019-2024) & (USD/g)
    Table 39. Global Alimta Price by Application (2025-2030) & (USD/g)
    Table 40. Global Alimta Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Alimta Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Alimta Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Alimta Sales Value by Region (2019-2024) & (%)
    Table 44. Global Alimta Sales Value by Region (2025-2030) & (%)
    Table 45. Global Alimta Sales Volume by Region (Kg): 2019 VS 2023 VS 2030
    Table 46. Global Alimta Sales Volume by Region (2019-2024) & (Kg)
    Table 47. Global Alimta Sales Volume by Region (2025-2030) & (Kg)
    Table 48. Global Alimta Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Alimta Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Alimta Average Price by Region (2019-2024) & (USD/g)
    Table 51. Global Alimta Average Price by Region (2025-2030) & (USD/g)
    Table 52. Key Countries/Regions Alimta Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Alimta Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Alimta Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Alimta Sales Volume, (2019-2024) & (Kg)
    Table 56. Key Countries/Regions Alimta Sales Volume, (2025-2030) & (Kg)
    Table 57. Eli Lilly Company Information
    Table 58. Eli Lilly Introduction and Business Overview
    Table 59. Eli Lilly Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 60. Eli Lilly Alimta Product Offerings
    Table 61. Eli Lilly Recent Development
    Table 62. Abbott Healthcare Company Information
    Table 63. Abbott Healthcare Introduction and Business Overview
    Table 64. Abbott Healthcare Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 65. Abbott Healthcare Alimta Product Offerings
    Table 66. Abbott Healthcare Recent Development
    Table 67. Cadila Healthcare Company Information
    Table 68. Cadila Healthcare Introduction and Business Overview
    Table 69. Cadila Healthcare Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 70. Cadila Healthcare Alimta Product Offerings
    Table 71. Cadila Healthcare Recent Development
    Table 72. Eagle Pharmaceuticals Company Information
    Table 73. Eagle Pharmaceuticals Introduction and Business Overview
    Table 74. Eagle Pharmaceuticals Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 75. Eagle Pharmaceuticals Alimta Product Offerings
    Table 76. Eagle Pharmaceuticals Recent Development
    Table 77. Key Raw Materials Lists
    Table 78. Raw Materials Key Suppliers Lists
    Table 79. Alimta Downstream Customers
    Table 80. Alimta Distributors List
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Alimta Product Picture
    Figure 2. Global Alimta Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Alimta Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Alimta Sales Volume (2019-2030) & (Kg)
    Figure 5. Global Alimta Sales Price (2019-2030) & (USD/g)
    Figure 6. Alimta Report Years Considered
    Figure 7. Global Alimta Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Alimta Players Sales Volume Ranking (2023) & (Kg)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Alimta Revenue in 2023
    Figure 10. Alimta Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 100mg Picture
    Figure 12. 500mg Picture
    Figure 13. Global Alimta Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Alimta Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Alimta Sales Volume by Type (2019 VS 2023 VS 2030) & (Kg)
    Figure 16. Global Alimta Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Alimta Price by Type (2019-2030) & (USD/g)
    Figure 18. Product Picture of Pleural Mesothelioma
    Figure 19. Product Picture of Non-small Cell Lung Cancer
    Figure 20. Global Alimta Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Alimta Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Alimta Sales Volume by Application (2019 VS 2023 VS 2030) & (Kg)
    Figure 23. Global Alimta Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Alimta Price by Application (2019-2030) & (USD/g)
    Figure 25. North America Alimta Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Alimta Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Alimta Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Alimta Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Alimta Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Alimta Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Alimta Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Alimta Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Alimta Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Alimta Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Alimta Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Alimta Sales Volume (%), (2019-2030)
    Figure 37. United States Alimta Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Alimta Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Alimta Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Alimta Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Alimta Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Alimta Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Alimta Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Alimta Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Alimta Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Alimta Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Alimta Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Alimta Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Alimta Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Alimta Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Alimta Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Alimta Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Alimta Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Alimta Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Alimta Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Alimta Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Alimta Sales Value by Application (%), 2023 VS 2030
    Figure 58. Alimta Industrial Chain
    Figure 59. Alimta Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed

Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

The global market for Alimta was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Alimta was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Alimta was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Alimta was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Alimta include Eli Lilly, Abbott Healthcare, Cadila Healthcare and Eagle Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Alimta, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Alimta by region & country, by Type, and by Application.

The Alimta market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alimta.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Alimta manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Alimta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Alimta in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.